Grupo de Investigación en Cáncer de Mama
NEONCOBREAST
Hospital Miguel Servet
Zaragoza, EspañaHospital Miguel Servet -ko ikertzaileekin lankidetzan egindako argitalpenak (5)
2021
-
Early imaging and molecular changes with neoadjuvant bevacizumab in stage ii/iii breast cancer
Cancers, Vol. 13, Núm. 14
2020
-
A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study
Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 420-428
-
Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO)
Gynecologic Oncology Reports, Vol. 33
-
Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)
Breast, Vol. 54, pp. 286-292
-
The impact of secondary cytoreductive surgery on survival in first recurrence of platinum sensitive epithelial ovarian cancer
European Journal of Gynaecological Oncology, Vol. 41, Núm. 4, pp. 523-530